Condition: Brain Tumor - Metastatic · Sponsor: University of Nebraska
This study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surgery to keep the cancer from coming back.
This description comes directly from the study's public registry record.
Project Coordinator · 402-559-0963 · IITOffice@unmc.edu
Taylor A Johnson, BS, MA · 402-559-0963 · taylora.johnson@unmc.edu
Always discuss trial participation with your own doctor first.
| Henry Ford | Detroit, Michigan, United States | Not Yet Recruiting |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04222062